VIDEO: Real world study shows apremilast safe to treat PsO, PsA patients
- Jeremy Visser
- Oct 5, 2022
- 1 min read
A real-world study of psoriasis (PsO) and psoriatic arthritis (PsA) patients with apremilast reported no new adverse events or safety signals with results comparable to previous clinical trials.
Comments